JPS5572115A - Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide - Google Patents

Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide

Info

Publication number
JPS5572115A
JPS5572115A JP10582079A JP10582079A JPS5572115A JP S5572115 A JPS5572115 A JP S5572115A JP 10582079 A JP10582079 A JP 10582079A JP 10582079 A JP10582079 A JP 10582079A JP S5572115 A JPS5572115 A JP S5572115A
Authority
JP
Japan
Prior art keywords
11dioxide
antibacterial activity
strengthening agent
agent made
penicillanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10582079A
Other languages
English (en)
Inventor
Aanesuto Baasu Uein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Original Assignee
PFIZER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER filed Critical PFIZER
Publication of JPS5572115A publication Critical patent/JPS5572115A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10582079A 1977-06-07 1979-08-20 Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide Pending JPS5572115A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21
US89045178A 1978-03-29 1978-03-29
US96376378A 1978-11-27 1978-11-27
US06/017,807 US4276285A (en) 1977-06-07 1979-03-05 Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid

Publications (1)

Publication Number Publication Date
JPS5572115A true JPS5572115A (en) 1980-05-30

Family

ID=27533756

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53068726A Expired JPS6056160B2 (ja) 1977-06-07 1978-06-07 β−ラクタマ−ゼ阻害剤としてのペニシラン酸1,1−ジオキシド
JP10582079A Pending JPS5572115A (en) 1977-06-07 1979-08-20 Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP53068726A Expired JPS6056160B2 (ja) 1977-06-07 1978-06-07 β−ラクタマ−ゼ阻害剤としてのペニシラン酸1,1−ジオキシド

Country Status (5)

Country Link
US (1) US4276285A (ja)
JP (2) JPS6056160B2 (ja)
AU (2) AU514926B2 (ja)
BE (1) BE877542R (ja)
MX (1) MX9203747A (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146784A (en) * 1981-02-02 1982-09-10 Pfizer Slightly water-soluble salt of penicillanic acid 1,1-dioxide
JPS58216191A (ja) * 1982-05-24 1983-12-15 フアイザ−・インコ−ポレ−テツド ペニシラン酸ジオキサイド前駆薬
JPS59104319A (ja) * 1982-12-06 1984-06-16 Chugai Pharmaceut Co Ltd 抗菌剤およびそのキツト
JPH02104528A (ja) * 1988-07-08 1990-04-17 Young S Kim 抗菌用組成物
JPH06234640A (ja) * 1993-01-12 1994-08-23 Suu Kim Yon β−ラクタマーゼ耐性抗生物質の組成物

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5661386A (en) * 1979-10-11 1981-05-26 Leo Pharm Prod Ltd Manufacture of penicillanic acid derivative
US4361513A (en) * 1980-12-11 1982-11-30 Pfizer Inc. Esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
US4351840A (en) * 1981-09-18 1982-09-28 Pfizer Inc. Antibacterial esters of resorcinol with ampicillin and penicillanic acid 1,1-dioxide derivatives
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
AT392903B (de) * 1987-10-08 1991-07-10 Hoechst Ag Pharmazeutische zubereitung enthaltend ein cephalosporin und ein penemantibiotikum
JP3236261B2 (ja) * 1998-04-09 2001-12-10 大塚化学株式会社 ハロゲン化β−ラクタム化合物の製造法
CN102952147B (zh) * 2011-08-16 2015-04-08 台州市信友医药化工有限公司 一种舒巴坦酸的合成方法
CN102702228A (zh) * 2012-06-26 2012-10-03 齐鲁天和惠世制药有限公司 一种舒巴坦制备方法
CN106699774A (zh) * 2016-12-30 2017-05-24 淄博鑫泉医药技术服务有限公司 舒巴坦钠的制备方法
KR102668212B1 (ko) * 2018-09-28 2024-05-23 삼성전자 주식회사 자동 초점 방법 및 이를 수행하는 전자 장치
CN111848645B (zh) * 2020-07-20 2024-03-08 青岛科技大学 一种制备舒巴坦酸的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
BE648188A (ja) * 1963-05-29 1964-09-16
US3536698A (en) * 1968-02-27 1970-10-27 Lilly Co Eli Simplified method for esterification of antibiotics via carbonate anhydride intermediates

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146784A (en) * 1981-02-02 1982-09-10 Pfizer Slightly water-soluble salt of penicillanic acid 1,1-dioxide
JPS58216191A (ja) * 1982-05-24 1983-12-15 フアイザ−・インコ−ポレ−テツド ペニシラン酸ジオキサイド前駆薬
JPS59104319A (ja) * 1982-12-06 1984-06-16 Chugai Pharmaceut Co Ltd 抗菌剤およびそのキツト
JPH02104528A (ja) * 1988-07-08 1990-04-17 Young S Kim 抗菌用組成物
JPH06234640A (ja) * 1993-01-12 1994-08-23 Suu Kim Yon β−ラクタマーゼ耐性抗生物質の組成物

Also Published As

Publication number Publication date
JPS6056160B2 (ja) 1985-12-09
AU6403080A (en) 1981-03-12
BE877542R (fr) 1980-01-07
US4276285A (en) 1981-06-30
AU4846579A (en) 1980-05-29
AU522487B2 (en) 1982-06-10
AU514926B2 (en) 1981-03-05
JPS543094A (en) 1979-01-11
MX9203747A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
PH15706A (en) Esters of penicillanic acid 1,1-dioxide
JPS5572115A (en) Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide
NZ187476A (en) Penicillanic acid 1,1-dioxides pharmaceutical compositions and intermediate 1-oxides
JPS54160317A (en) Manufacture of dimethylaminomethylene bisphosphoric acid
ZA792004B (en) Novel compounds of sterilizing activity
JPS543058A (en) Production of ascorbic acid
JPS5463026A (en) Nncarboxyalkaneeaminoalkaneepolyphosphoric acid* its alkali salt and manufacture
JPS5419913A (en) Alphaahalomethyl derivative of alphaaamino acid
JPS55154977A (en) Penicillanic acid derivative* its manufacture and use
JPS5430160A (en) Novel indoleacetoxyacetylamino acid compound * production thereof and medical use
JPS5414916A (en) Alphaaacetylene derivative of alphaaamino acid
GB2022073B (en) Derivatives of 5-nitro-imidazole with anti-protozoic activity
GB2002347B (en) Derivatives of amidino penicillanic acid
JPS5419944A (en) Production of antiitumor agent
JPS5495573A (en) Manufacture of 3*44methylene dioxymandelic acid
NZ187327A (en) Preparation of 6-(-)-alpha-amino-para-hydroxy phenylacetamido) penicillanic acid (amoxycillin)
GB2002764B (en) Derivatives of n-substituted-2-aminobenzoic acid
JPS55120588A (en) Penicillanic acid 1*11dioxide and manufacture and intermediate of same
JPS5448749A (en) Manufacture of 11aminoo44bromoanthraquinonee22sulfonic acid
JPS53136531A (en) Production of antiisweat agent
JPS5359694A (en) Production of sstriazoloo *1*55a**pyridinee22yll5*77 dimethyllphosphoric acid derivative and harmful organism combaiting agent containing same
EG13473A (en) Derivatives of oxanilic acid
JPS5452008A (en) Manufacture of substituted urea
JPS5392744A (en) Derivative of omegaaaryloxyy133 prostin acid
GB2006255B (en) Aqueous solutions of cleaning agents